F
Francesco Rubino
Researcher at King's College London
Publications - 133
Citations - 12607
Francesco Rubino is an academic researcher from King's College London. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 41, co-authored 131 publications receiving 10277 citations. Previous affiliations of Francesco Rubino include Sapienza University of Rome & HealthPartners.
Papers
More filters
Journal ArticleDOI
The influence of obesity on short- and long-term outcomes after laparoscopic surgery for colon cancer: A case-matched study of 152 patients
Tomoki Makino,Tomoki Makino,Koiana Trencheva,Parul J. Shukla,Francesco Rubino,Changhua Zhuo,Changhua Zhuo,Raghava S. Pavoor,Jeffrey W. Milsom +8 more
TL;DR: Laroscopic colonic resection, when performed for selected patients, appears to be a safe and reasonable option in obese patients with colon cancer resulting in similar short-term and oncologic outcomes as nonobese patients.
Journal ArticleDOI
Gastrointestinal surgery as treatment for type 2 diabetes.
Tracy-Ann Moo,Francesco Rubino +1 more
TL;DR: The implications of ‘diabetes surgery’ are vast, and could dramatically change the face of diabetes as the authors know it today.
Journal ArticleDOI
Gastric Inhibitory Peptide Controls Adipose Insulin Sensitivity via Activation of cAMP-response Element-binding Protein and p110β Isoform of Phosphatidylinositol 3-Kinase
Sameer Mohammad,Lavoisier S. Ramos,Jochen Buck,Lonny R. Levin,Francesco Rubino,Timothy E. McGraw +5 more
TL;DR: The effect of GIP on adipocyte insulin sensitivity requires activation of both the cAMP/protein kinase A/CREB signaling module and p110β phosphoinositol-3′ kinase, establishing a novel signal transduction pathway modulating insulin action in adipocytes.
Journal ArticleDOI
Metabolic Surgery for Type 2 Diabetes: Changing the Landscape of Diabetes Care.
TL;DR: This month’s issue of Diabetes Care includes 11 articles that report the latest data supporting bariatric/metabolic surgery as a new treatment option in the management of type 2 diabetes mellitus, and new evidence-based guidelines for surgical treatment of T2D are reported.
Journal ArticleDOI
IDF's view of bariatric surgery in type 2 diabetes
TL;DR: The IDF statement recognises that bariatric surgery is an appropriate treatment for obese people with type 2 diabetes who do not achieve recommended targets with available therapies, especially in cases with other major comorbidities (eg, hypertension and dyslipidaemia).